Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in Belgium
3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Where
- Edegem
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 - Phase 2Taking peopleA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Where
- Edegem
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614 - Phase 4Not yet taking people in BelgiumA study on stopping versus continuing beta-blockers in patients with hypertrophic cardiomyopathy treated with mavacamten
- Where
- Edegem, Genk, Hasselt, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 90
- Run by
- Ziekenhuis Oost Limburg
See details and how to join2026-526612-36-00